FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022366963> ?p ?o ?g. }

• W2022366963 endingPage "1894" @default.
• W2022366963 startingPage "1889" @default.
• W2022366963 abstract "The epidermal growth factor receptor (EGFR) mutation status is a validated biomarker for the stratification of EGFR-tyrosine kinase inhibitor (EGFR-TKIs) treatment in patients with non-small cell lung cancer (NSCLC); however, its use is limited in patients with wild-type EGFR, and new biomarkers are needed. We hypothesized that the serum concentration of heparan sulfate (HS), which activates oncogenic growth factor receptor signaling through EGFR and non-EGFR signaling pathways, may be a novel glycobiological biomarker for EGFR-TKIs treatment in NSCLC.The pretreatment serum HS concentrations were determined using enzyme-linked immunosorbent assay in 83 patients with stage IV non-small cell lung adenocarcinoma who received EGFR-TKIs treatment. The relationship between the serum HS concentrations and patient characteristics, tumor response, progression-free survival (PFS), and overall survival (OS) were analyzed.Patient sex, performance status, smoking history, and EGFR mutation status were associated with tumor response. The serum HS concentrations were significantly higher among patients with progressive disease than among those without progressive disease (p = 0.003). Furthermore, the serum HS concentrations were strongly associated with a poor PFS and OS in a univariate Cox analysis (p = 0.0022 and p = 0.0003, respectively). A stratified multivariate Cox model according to the EGFR mutation status showed that higher HS concentrations were significantly associated with a shorter PFS and OS (p = 0.0012 and p = 0.0003).We concluded that a high-serum HS concentration was strongly related to a poor treatment outcome of EGFR-TKIs and may be a promising noninvasive and repeatable glycobiological biomarker in cancer treatment." @default.
• W2022366963 created "2016-06-24" @default.
• W2022366963 creator A5000324980 @default.
• W2022366963 creator A5003648443 @default.
• W2022366963 creator A5004282323 @default.
• W2022366963 creator A5014216457 @default.
• W2022366963 creator A5015524135 @default.
• W2022366963 creator A5018690593 @default.
• W2022366963 creator A5045832805 @default.
• W2022366963 creator A5048801191 @default.
• W2022366963 creator A5058549884 @default.
• W2022366963 creator A5062818098 @default.
• W2022366963 creator A5066153884 @default.
• W2022366963 creator A5068013727 @default.
• W2022366963 creator A5077306744 @default.
• W2022366963 creator A5078287634 @default.
• W2022366963 creator A5081654329 @default.
• W2022366963 date "2011-11-01" @default.
• W2022366963 modified "2023-10-16" @default.
• W2022366963 title "Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma" @default.
• W2022366963 cites W1524048408 @default.
• W2022366963 cites W1535201509 @default.
• W2022366963 cites W1590794385 @default.
• W2022366963 cites W1973828570 @default.
• W2022366963 cites W1985264867 @default.
• W2022366963 cites W1991247964 @default.
• W2022366963 cites W1993918000 @default.
• W2022366963 cites W1996795546 @default.
• W2022366963 cites W1998971866 @default.
• W2022366963 cites W2006323138 @default.
• W2022366963 cites W2006470775 @default.
• W2022366963 cites W2008581828 @default.
• W2022366963 cites W2010631330 @default.
• W2022366963 cites W2017952250 @default.
• W2022366963 cites W2036469214 @default.
• W2022366963 cites W2043490832 @default.
• W2022366963 cites W2043696829 @default.
• W2022366963 cites W2045965305 @default.
• W2022366963 cites W2064326390 @default.
• W2022366963 cites W2075500765 @default.
• W2022366963 cites W2089716357 @default.
• W2022366963 cites W2119351872 @default.
• W2022366963 cites W2121271975 @default.
• W2022366963 cites W2129360604 @default.
• W2022366963 cites W2132157071 @default.
• W2022366963 cites W2138297714 @default.
• W2022366963 cites W2146404049 @default.
• W2022366963 cites W2150436360 @default.
• W2022366963 cites W2152778072 @default.
• W2022366963 cites W2153064305 @default.
• W2022366963 cites W2153477391 @default.
• W2022366963 cites W2161821474 @default.
• W2022366963 cites W2163402367 @default.
• W2022366963 cites W2171244087 @default.
• W2022366963 doi "https://doi.org/10.1097/jto.0b013e3182286d41" @default.
• W2022366963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21964526" @default.
• W2022366963 hasPublicationYear "2011" @default.
• W2022366963 type Work @default.
• W2022366963 sameAs 2022366963 @default.
• W2022366963 citedByCount "7" @default.
• W2022366963 countsByYear W20223669632012 @default.
• W2022366963 countsByYear W20223669632013 @default.
• W2022366963 countsByYear W20223669632014 @default.
• W2022366963 countsByYear W20223669632019 @default.
• W2022366963 countsByYear W20223669632020 @default.
• W2022366963 countsByYear W20223669632022 @default.
• W2022366963 crossrefType "journal-article" @default.
• W2022366963 hasAuthorship W2022366963A5000324980 @default.
• W2022366963 hasAuthorship W2022366963A5003648443 @default.
• W2022366963 hasAuthorship W2022366963A5004282323 @default.
• W2022366963 hasAuthorship W2022366963A5014216457 @default.
• W2022366963 hasAuthorship W2022366963A5015524135 @default.
• W2022366963 hasAuthorship W2022366963A5018690593 @default.
• W2022366963 hasAuthorship W2022366963A5045832805 @default.
• W2022366963 hasAuthorship W2022366963A5048801191 @default.
• W2022366963 hasAuthorship W2022366963A5058549884 @default.
• W2022366963 hasAuthorship W2022366963A5062818098 @default.
• W2022366963 hasAuthorship W2022366963A5066153884 @default.
• W2022366963 hasAuthorship W2022366963A5068013727 @default.
• W2022366963 hasAuthorship W2022366963A5077306744 @default.
• W2022366963 hasAuthorship W2022366963A5078287634 @default.
• W2022366963 hasAuthorship W2022366963A5081654329 @default.
• W2022366963 hasBestOaLocation W20223669631 @default.
• W2022366963 hasConcept C121608353 @default.
• W2022366963 hasConcept C126322002 @default.
• W2022366963 hasConcept C143998085 @default.
• W2022366963 hasConcept C170493617 @default.
• W2022366963 hasConcept C2776256026 @default.
• W2022366963 hasConcept C2778820342 @default.
• W2022366963 hasConcept C2779438470 @default.
• W2022366963 hasConcept C2781182431 @default.
• W2022366963 hasConcept C2781197716 @default.
• W2022366963 hasConcept C42362537 @default.
• W2022366963 hasConcept C502942594 @default.
• W2022366963 hasConcept C55493867 @default.
• W2022366963 hasConcept C71924100 @default.
• W2022366963 hasConcept C86803240 @default.
• W2022366963 hasConceptScore W2022366963C121608353 @default.

• next